Laurel Wealth Advisors (North Carolina)’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-18
Closed -$1.46K – 447
2025
Q4
$1.46K Buy
+18
New +$1.55K ﹤0.01% 622
2025
Q2
– Sell
-18
Closed -$1.51K – 465
2025
Q1
$1.51K Hold
18
– – ﹤0.01% 610
2024
Q4
$1.66K Hold
18
– – ﹤0.01% 632
2024
Q3
$1.67K Buy
+18
New +$1.56K ﹤0.01% 595

Other funds holding LMAT

Laurel Wealth Advisors (North Carolina)'s LMAT Position: Q1 2026 in Review

Laurel Wealth Advisors (North Carolina) sold out of LeMaitre Vascular (LMAT) in Q1 2026, closing a stake of 18 shares — an estimated $1.46K sold.

Laurel Wealth Advisors (North Carolina) first reported a position in LMAT in Q3 2024 and held it in 4 quarters. The position peaked at $1.67K in Q3 2024. 340 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Laurel Wealth Advisors (North Carolina) reported no remaining LeMaitre Vascular position as of Q1 2026 after selling out during the quarter.
  • Laurel Wealth Advisors (North Carolina) sold 18 LeMaitre Vascular shares in Q1 2026, an estimated $1.46K.
  • Laurel Wealth Advisors (North Carolina) first reported a position in LeMaitre Vascular in Q3 2024 and held it in 4 quarters.
  • Laurel Wealth Advisors (North Carolina)'s LeMaitre Vascular position peaked at $1.67K in Q3 2024.
  • 340 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q1 2026, filed 13 May 2026.